Historical award
Pine Pharmaceuticals LLC
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (10 days old).
Fiscal year 2026: data through (10 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $91,897.70
- Potential award value
- $91,897.70
- Total obligated to date
- $91,897.70
Source date: Nov 9, 2026
Recorded work
NIDDK: PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE.
Award activity
- Obligations in covered fiscal years
- $91,897.70
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75N94026F00001_7529_75N94024D00003_7529